Cell Signaling Technology

PTEN (138G6) Rabbit Monoclonal Antibody

#9559 · $152,855

69
Evidence Score · Well-Established
Used by 802 independent labs across 895 papers. How we score this →
100
Citing papers
9.8k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer33MicroRNA in disease regulation11Circular RNAs in diseases8Cancer-related molecular mechanisms research7Cancer, Hypoxia, and Metabolism6Cancer Mechanisms and Therapy5Extracellular vesicles in disease5Hippo pathway signaling and YAP/TAZ4

Papers citing this product

1
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Oncology·2017·474 cit.·DOI
2
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
Science·2013·410 cit.·DOI
3
mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
Cancer Cell·2009·401 cit.·DOI
4
Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN
Molecular Cancer·2019·357 cit.·DOI
5
Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
Nature Communications·2017·342 cit.·DOI
6
Mesenchymal stem cells deliver exogenous miR‐21 <i>via</i> exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration
Journal of Cellular and Molecular Medicine·2017·311 cit.·DOI
7
Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
Molecular Cancer·2018·298 cit.·DOI
8
Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit
Molecular Cancer·2020·239 cit.·DOI
9
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Breast Cancer Research·2011·184 cit.·DOI
10
MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating <i>SOCS1</i>, <i>SOCS6</i>, and <i>PTEN</i>
Oncotarget·2016·182 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
PTEN Antibody (YA6253)RabbitMedChemExpress69—200
Alexa Fluor® 647 Anti-PTEN antibody [EPR22636-122]RabbitAbcam69—200
Anti-PTEN antibody [PTEN/2110] - BSA and Azide freeMouseAbcam69—200
PTEN AntibodyRabbitCell Signaling Technology69$317100
PTEN (D5G7) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology69$161,351100
PTEN (D3Q6G) Mouse Monoclonal AntibodyMouseCell Signaling Technology69$158,34877
PTEN Rabbit mAbRabbitZen Bio69—74
PTENMouseAgilent/Dako69—29
TotalSeq™-C1510 anti-PTENRatBioLegend69—9
Anti-PTEN antibody [EPR9941]RabbitAbcam69—5
TotalSeq™-B1510 anti-PTENRatBioLegend69—3
PTENMouseProteintech69$4493
PTEN (D3Q6G) Mouse Monoclonal Antibody (BSA and Azide Free)MouseCell Signaling Technology69$8651
Anti-PTEN Mouse mAb (EMD-4B8)MouseMillipore69——
Anti-PTEN Mouse mAb (EMD-15E10)MouseMillipore69——
Anti-PTEN Mouse mAb (EMD-4B8)mouseMillipore69——
Anti-PTEN Mouse mAb (EMD-15E10)mouseMillipore69——
PTEN (10P01)MouseSanta Cruz Biotechnology69——
Anti-PTEN Monoclonal Antibody, UnconjugatedLeica Biosystems69——
PTEN antibodyrabbitFitzgerald Industries International69——

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.